Application of genomic bioinformatic tools in clinical psychiatry and counseling.

Authors

Angela Muñoz, Trinidad Kahler, M Leonor Bustamante, Camila Vargas, Fernanda Vargas, Marcelo Arancibia

Published in

Medwave. Volume 26. Issue 7. Pages e3225. Aug 21, 2026. Epub Aug 21, 2026.

Abstract

Genomic medicine has introduced transformative tools for psychiatric practice, facilitating the diagnosis of complex cases through the identification of genetic variants. The gene encodes a key component of the histone methyltransferase complex. Mutations in this gene have been linked to neurodevelopmental disorders and schizophrenia, particularly in cases with early onset and cognitive impairment. The aim of this article is to describe the application of genomic tools and international criteria for interpreting genetic pathogenicity in psychiatric clinical practice, using as a model. Based on an illustrative clinical case of a 13-year-old patient with psychotic symptoms, we conducted a comparative analysis of two single-nucleotide variants in (c.2209C>A and c.2209C>T). Genomic databases (Ensembl, ClinVar, gnomAD) and prediction tools (PolyPhen-2, MutationTaster, Align-GVGD) were used, following the American College of Medical Genetics and Genomics guidelines. The c.2209C>T (nonsense) variant was classified as pathogenic due to its truncating effect and prior reports. In contrast, the c.2209C>A (missense) variant, initially of uncertain significance, was reclassified as likely benign after a familial segregation study showed the variant was inherited from an unaffected parent. The integration of genomic tools allows for a precise approach to neuropsychiatric phenotypes. However, bioinformatic analysis must be complemented by clinical correlation and cosegregation studies. Finally, genetic counseling is emphasized as an essential process to integrate technical findings with the psychological and educational needs of the patient and their family.

PMID:
42628034
Bibliographic data and abstract were imported from PubMed on 22 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.